对于先天性心脏病患者的数字情绪调节干预:随机临床试验
Luise Pruessner1, Steffen Hartmann1, Anna-Lena Ehmann2,3
1Department of Psychology, Heidelberg University, Heidelberg, Germany.
JAMA network open
|October 24, 2025
概括
一个定制的数字干预显著改善了先天性心脏病 (CHD) 的成年人的情绪调节和心理社会福祉. 一个通用计划显示了延迟的好处,强调了针对慢性疾病的个性化数字心理健康工具的价值.
科学领域:
- 数字健康干预措施 数字健康干预措施
- 慢性疾病中的心理社会结果.
- 情绪调节策略 情绪调节策略
背景情况:
- 先天性心脏病 (CHD) 与情绪困扰和降低生活质量有关.
- 对于心血管疾病患者而言,存在有限的基于证据的心理社会治疗方法.
- 数字干预提供了一个可扩展的方法来满足这些需求.
研究的目的:
- 评估定制和一般数字情绪调节干预措施的有效性.
- 将这些干预措施与心脏病患者的常规护理进行比较.
主要方法:
- 一个三臂,并行组随机临床试验,涉及患有心脏病的成年人.
- 参与者接受了为期4周的数字计划 (定制或一般) 或通常的护理.
- 结果包括情绪调节困难,剧目,幸福感,生活满意度,焦虑,抑郁和压力.
主要成果:
- 与常规护理相比,定制的数字程序显著减少了情绪调节困难,并改善了二次结果.
- 总体方案最初显示了对压力的好处,在随访时得到了更广泛的改善.
- 量身定制的干预措施的好处在随访时保持不变,与一般计划相比,情绪调节曲目获得了更大的收益.
结论:
- 量身定制的数字情绪调节干预措施有效地改善了患有心脏病的成年人的心理社会结果.
- 这些发现强调了个性化数字工具在慢性疾病中管理心理健康的潜力.
- 数字干预可以为患有心脏病的人提供可访问和有效的支持.
更多相关视频
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
427
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
427
Dysrhythmias VI: Management of Dysrhythmias
373
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
373
Mitral Regurgitation IV: Nursing Management
279
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
279
Heart Failure V: Medical Management
195
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
195
Cardiomyopathy III: Hypertrophic Cardiomyopathy
354
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
354


